NEW YORK, July 23 (GenomeWeb News) - Molecular Devices yesterday reported increased revenues and earnings for the second quarter.
Revenues totaled $32.2 million, up from $28.5 million during the same quarter last year.
R&D expenses stayed flat at $4.7 million, compared to $4.8 million during the same period a year ago.
The company's net income for the quarter was $2.5 million, or $.17 per share, up from $1.8 million, or $.12 per share, during the same period in 2003.
As of June 30, the company had $54.2 million in cash and cash equivalents.